PH COVID-19 Vaccine with Registration

• Children 5 to 11 years old must register for a vaccination clinic that offers the Pfizer vaccine and be accompanied by a parent/legal guardian or present a signed written consent from a parent/legal guardian and be accompanied by an adult.
• Children 6 to 11 years old must register for a vaccination clinic that offers the Moderna vaccine and be accompanied by a parent/legal guardian or present a signed written consent from a parent/legal guardian and be accompanied by an adult. Download Minor Consent Descargue El Formulario De Consentimiento Del Menor Aquí
  Pediatric Pfizer (5 – 11 years old):
  - 2-dose series (second primary dose given -8 weeks after first primary dose).
  - For Moderately or Severely Immunocompromised individuals, a 3rd dose can be administered 4 weeks after receiving 2nd dose.
  - Bivalent Booster dose is recommended 2 months after last primary dose.
  - For people who previously received a monovalent booster dose(s), the bivalent booster is administered at least 2 months after the last monovalent booster dose.
   
  Pediatric Moderna (6 – 11 years old):
  - 2-dose series (second primary dose given 4-8 weeks after first primary dose).
  - For Moderately or Severely Immunocompromised individuals, a 3rd dose can be administered 4 weeks after receiving 2nd dose.
  - Bivalent Booster dose is recommended 2 months after last primary dose.
  - For people who previously received a monovalent booster dose(s), the bivalent booster is administered at least 2 months after the last monovalent booster dose.
   
• Additional eligibility information
• Additional Pfizer information
• Additional Moderna information

• Teenagers 12 to 17 years old must register for a vaccination clinic that offers the Pfizer, Moderna or Novavax vaccine and be accompanied by a parent/legal guardian or present a signed written consent from a parent/legal guardian and be accompanied by an adult. Download Minor Consent
  Descargue El Formulario De Consentimiento Del Menor Aquí

  *If scheduling for Novavax, please still complete the Minor Consent Form*

  Pfizer:
  - 2-dose series (second primary dose given 3-8 weeks after first primary dose).
  - For Moderately or Severely Immunocompromised individuals, a 3rd dose can be administered 4 weeks after receiving 2nd dose
  - Bivalent Booster dose is recommended 2 months after last primary dose.
  - For people who previously received a monovalent booster dose(s), the bivalent booster is administered at least 2 months after the last monovalent booster dose.
  
  Moderna:
  - 2-dose series (second primary dose given 4-8 weeks after first primary dose).
  - For Moderately or Severely Immunocompromised individuals, a 3rd dose can be administered 4 weeks after receiving 2nd dose
  - Bivalent Booster dose is recommended 2 months after last primary dose.
  - For people who previously received a monovalent booster dose(s), the bivalent booster is administered at least 2 months after the last monovalent booster dose.
  
  Novavax:
  - 2-dose series (second primary dose given 3-8 weeks after first primary dose).
  - Bivalent Booster dose is recommended 2 months after 2nd primary dose.
  - For people who previously received a monovalent booster dose(s), the bivalent booster is administered at least 2 months after the last monovalent booster dose.
  
  Monovalent mRNA COVID-19 vaccines are no longer authorized by FDA as booster doses for individuals 12 years of age and older
  - More information on monovalent/bivalent COVID-19 vaccine booster
   
• Johnson & Johnson vaccines can only be given to individuals age 18 years and older.
• Additional eligibility information
• Booster dose information
• More information on Novavax

• Individuals 18 and older may register for a vaccination clinic that offers any of the available vaccines: Pfizer, Moderna, Johnson & Johnson, or Novavax

Pfizer:
- 2-dose series (second primary dose given 3-8 weeks after first primary dose).
- For Moderately or Severely Immunocompromised individuals, a 3rd dose can be administered 4 weeks after receiving 2nd dose
- Bivalent Booster dose is recommended 2 months after last primary dose.
- For people who previously received a monovalent booster dose(s), the bivalent booster is administered at least 2 months after the last monovalent booster dose.

Moderna:
- 2-dose series (second primary dose given 4-8 weeks after first primary dose).
- For Moderately or Severely Immunocompromised individuals, a 3rd dose can be administered 4 weeks after receiving 2nd dose
- Bivalent Booster dose is recommended 2 months after last primary dose.
- For people who previously received a monovalent booster dose(s), the bivalent booster is administered at least 2 months after the last monovalent booster dose.

Novavax:
- 2-dose series (second primary dose given 3-8 weeks after first primary dose).
- Bivalent Booster dose is recommended 2 months after 2nd primary dose.
- For people who previously received a monovalent booster dose(s), the bivalent booster is administered at least 2 months after the last monovalent booster dose.

Johnson & Johnson:
- 1-dose series (a booster dose given at least 2 months after the first primary dose. A 2nd booster dose given at least 4 months after the 1st booster has been received)

Monovalent mRNA COVID-19 vaccines are no longer authorized by FDA as booster doses for individuals 12 years of age and older.
- More information on monovalent/bivalent COVID-19 vaccine booster
 

•  
• Booster dose information
• More information on Novavax

6 months - 4 years

• Regardless of Immune Response:
  - No recommendation for any booster or additional doses at this time.

5 years

• Regular Immunity:
  - Should receive the Updated Booster (bivalent) dose of Pfizer at least two months after receiving their last dose, regardless of type (primary series or booster).
• Compromised Immunity:
  - Should receive an additional (monovalent) dose of Pfizer at least four weeks after receiving the second dose in their primary series.
  - Should receive the Updated Booster (bivalent) dose of Pfizer at least two months after receiving their last dose, regardless of type (primary series or booster).

6 years+

• Regular Immunity:
  - Should receive the Updated Booster (bivalent) dose at least two months after receiving their last dose, regardless of type (primary series or booster).
• Compromised Immunity:
  - Should receive an additional (monovalent) dose of Pfizer at least four weeks after receiving the second dose of their primary series.
  - Should receive the Updated Booster (bivalent) dose at least two months after receiving their last dose, regardless of type (primary series or booster).

• Additional eligibility information
• Covid-19 Vaccine & Booster FAQ’s
• Additional COVID-19 Vaccine Booster Dose Information

6 months - 4 years

• Regardless of Immune Response:
  - No recommendation for any booster or additional doses at this time.

5 years

• Regular Immunity:
  - Should receive the Updated Booster (bivalent) dose of Pfizer at least two months after receiving their second dose.
• Compromised Immunity:
  - Should receive an additional (monovalent) dose of Moderna at least four weeks after receiving the second dose in their primary series.
  - Should receive the Updated Booster (bivalent) dose of Pfizer at least two months after receiving their additional/third dose of the primary series.

6 years+

• Regular Immunity:
  - Should receive the Updated Booster (bivalent) dose at least two months after receiving their last dose, regardless of type (primary series or booster).
• Compromised Immunity:
  - Should receive an additional (monovalent) dose of Moderna at least four weeks after receiving the second dose of their primary series.
  - Should receive the Updated Booster (bivalent) dose at least two months after receiving their last dose, regardless of type (primary series or booster).

• Additional eligibility information
• Covid-19 Vaccine & Booster FAQ’s
• Additional COVID-19 Vaccine Booster Dose Information

12 years+

• Regardless of Immune Response:
  - Should receive the Updated Booster (bivalent) dose at least two months after their last dose, regardless of type (primary series or booster).

18 years+

• Regardless of Immune Response:
  - Should receive the Updated Booster (bivalent) dose at least two months after their last dose, regardless of type (primary series or booster).
  - In some limited situations, may receive the Novavax booster dose at least six months after completion of their primary series. Only for people for whom an mRNA Updated Booster is not accessible or clinically appropriate, or who would otherwise not receive a booster dose.

• Additional eligibility information
• Covid-19 Vaccine & Booster FAQ’s
• Additional COVID-19 Vaccine Booster Dose Information

18 years+

• Regular Immunity:
  - Should receive the Updated Booster (bivalent) dose at least two months after their last dose, regardless of type (primary series or booster).
  - In some limited situations, may receive the J&J booster dose at least two months after completion of their first dose. Only for people for whom an mRNA Updated Booster is not accessible or clinically appropriate, or who would otherwise not receive a booster dose.
• Compromised Immunity:
  - Should receive an additional (monovalent) dose of an mRNA vaccine at least four weeks after receiving the first dose of their primary series.
  - Should receive the Updated Booster (bivalent) dose at least two months after receiving their last dose, regardless of type (primary series or booster).

• Additional eligibility information
• Covid-19 Vaccine & Booster FAQ’s
• Additional COVID-19 Vaccine Booster Dose Information

The CDC recommends a third vaccine dose for certain groups of people with weakened immune systems who received either the Pfizer-BioNTech or Moderna COVID-19 vaccine. Some examples include:

• Receiving active cancer treatment for tumors or cancers of the blood
• Received an organ transplant and are taking medicine to suppress the immune system
• Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system
• Moderate or severe primary immunodeficiency
• Advanced or untreated HIV infection
• Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response
  • Additional eligibility information
  • Covid-19 Vaccine & Booster FAQ’s

Please talk to your healthcare provider about your medical condition, and whether getting an additional dose is appropriate for you.